Nectin4/FAP-targeted CAR-T cell therapy (The Sixth Affiliated Hospital of Wenzhou Medical University)

N/A

Report date: 2024/11/22 20:00:28

Base Information

Drug NameNectin4/FAP-targeted CAR-T cell therapy (The Sixth Affiliated Hospital of Wenzhou Medical University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionFibroblast activation protein alpha modulatorsNectin-4 modulators
TargetsNectin-4Prolyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesWenzhou Medical UniversityThe Sixth Affiliated Hospital Of Wenzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Sixth Affiliated Hospital Of Wenzhou Medical University
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A